Attovia Therapeutics Appoints Hubert Chen As Chief Medical Officer

Mar 26, 2024•over 1 year ago

Position

Chief Medical Officer

Company

Attovia Therapeutics

Hubert Chen

San CarlosTherapeuticsBiotechnology

Description

Attovia Therapeutics has announced the appointment of Hubert Chen, M.D., MPH, as Chief Medical Officer, effective March 21, 2024. Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee

Company Information

Company

Attovia Therapeutics

Location

San Carlos, California, United States

About

Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases. We leverage ATTOBODY™, our proprietary biologics platform, to generate first-in-class and best-in-class bispecifics and multispecifics.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Attovia Therapeutics Appoints Hubert Chen As Chief Medical Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information